Former Executive Vice President and Chief Financial Officer (7) · ADMA BIOLOGICS, INC. (ADMA)

Brian Lenz

A named executive officer of ADMA BIOLOGICS in every fiscal year CompBrief holds from FY2017 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$682,801

Salary $127,885Stock awards $0

FY2023: $1,965,360

4th of 4 named executive officers at Adma Biologics by FY2024 total.

4 named officers on file for ADMA BIOLOGICS, FY2024

Brian Lenz’s pay file — $29

  • 8 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • ADMA’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ADMA BIOLOGICS’s whole pay program stands against its peers

  • ADMA BIOLOGICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ADMA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 15, 2025 (DEF 14A).

Free

Get Brian Lenz’s full pay file as a PDF — free

More than this page: up to 10 years of Brian’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Brian Lenz compensation by year

ADMA BIOLOGICS Summary Compensation Table · all 8 fiscal years held
In US dollars, as ADMA BIOLOGICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Salary$360,500$366,800$390,000$420,000$432,600$445,578$475,000$127,885
Bonus$158,656$107,105$195,000$222,600$420,284$471,755$334,875$0
Stock awards$0$0$0$116,600$1,146,250$229,625$452,836$0
Option awards$486,835$312,230$380,429$167,544$204,200$288,321$595,607$0
Non-equity incentive$0$0$0$0$0—$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0
All other$89,965$153,959$156,725$160,274$163,346$165,785$107,042$554,916
Total$1,095,956$940,094$1,122,154$1,087,018$2,366,680$1,601,064$1,965,360$682,801

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ADMA BIOLOGICS, INC. DEF 14A filed April 15, 2025, accession 0001140361-25-013967, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ADMA BIOLOGICS, INC. filed document, accession 0001140361-25-013967. Every figure is read from that document and cited to the page and table it appears in. Filed April 15, 2025.

$1.1M
$940K
$1.1M
$1.1M
$2.4M
$1.6M
$2.0M
$683K
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU101,382$1,738,701—
RSU68,750$1,179,062—
RSU13,750$235,812—
Option85,938—$1.67
Option152,070—$3.35
Option5,792—$2.35

Per the Outstanding Equity Awards at Fiscal Year-End table in ADMA BIOLOGICS, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

ADMA BIOLOGICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Adam GrossmanPresident, Chief Executive Officer and Director$7,918,734
Kaitlin KestenbergChief Operating Officer & Senior Vice President of Compliance$3,340,020
Brad TadeChief Financial Officer and Treasurer$2,936,435
Brian Lenz · this pageFormer Executive Vice President and Chief Financial Officer (7)$682,801

The full ADMA BIOLOGICS compensation record

free company brief

This page is one person within ADMA BIOLOGICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ADMA BIOLOGICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Brian Lenz's compensation dossier · One-time report. No refunds.